Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Liabilities and Shareholders Equity (2009 - 2026)

Danaher (DHR) posted Liabilities and Shareholders Equity of $92.4 billion for Q2 2026, up 10.56% on a QoQ basis from $83.5 billion in Q1 2026, and up 13.17% year-over-year from $81.6 billion in Q2 2025.

Analysis

Danaher (DHR) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Danaher has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $92.4 billion in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 13.17% year-over-year to $92.4 billion in Q2 2026; TTM through Jun 2026 was $339.3 billion, a 6.39% increase from a year earlier, with the FY2025 full-year figure at $83.5 billion, up 7.64% from the prior year.
  • Liabilities and Shareholders Equity was $92.4 billion for Q2 2026 at Danaher, up from $83.5 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $92.4 billion in Q2 2026, with the low at $77.5 billion in Q4 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $82.9 billion, with a median of $83.4 billion recorded in 2022.
  • The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity slipped 8.22% in 2024, then increased 13.17% in 2026.
  • Over 5 years, Liabilities and Shareholders Equity stood at $84.4 billion in 2022, then climbed by 0.16% to $84.5 billion in 2023, then retreated by 8.22% to $77.5 billion in 2024, then grew by 7.64% to $83.5 billion in 2025, then rose by 10.67% to $92.4 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $92.4 billion (Q2 2026), $83.5 billion (Q1 2026), and $83.5 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 113.17 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 92.37 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 13.97 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 6.65 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 12.05 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 2.59 Bn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 10.25 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 2.95 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 1.03 Bn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 6.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 92.37 Bn
Mar 27, 2026 83.54 Bn
Dec 31, 2025 83.46 Bn
Sep 26, 2025 79.90 Bn
Jun 27, 2025 81.62 Bn
Mar 28, 2025 79.12 Bn
Dec 31, 2024 77.54 Bn
Sep 27, 2024 80.62 Bn
Jun 28, 2024 78.56 Bn
Mar 29, 2024 83.40 Bn
Dec 31, 2023 84.49 Bn
Sep 29, 2023 87.73 Bn
Jun 30, 2023 84.90 Bn
Mar 31, 2023 85.04 Bn
Dec 31, 2022 84.35 Bn
Sep 30, 2022 81.03 Bn
Jul 1, 2022 81.81 Bn
Apr 1, 2022 83.39 Bn
Dec 31, 2021 83.18 Bn
Oct 1, 2021 82.50 Bn